== Study Methods ==
 Subjects enrolment will last 20 months and the overall duration of the study will be approximately 3 years . 
 Lanreotide ATG 120 mg and TMZ 250 mg will be provided free of charge by the Sponsor to the investigational sites 
 under its commercial packaging, for a maximum of 12 months .  Subjects are expected to participate in this study 
 for a minimum of 53 weeks and up to 56 weeks . Subjects can be withdrawn from the study at any time if the 
 investigator or the sponsor decides that the subject is not in compliance with the study protocol .

